Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Katz

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Managed Care Pharmacy : JMCP|July 7, 2005
Direct costs of opioid abuse in an insured population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.
Pain|May 12, 2007
Development and validation of the Current Opioid Misuse MeasureStephen F Butler, Simon H Budman, Kathrine C Fernandez, et al.
Harm Reduction Journal|February 7, 2006
Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusersStephen F Butler, Christine Benoit, Simon H Budman, et al.
Pain|June 24, 2011
Efficacy and safety of tanezumab in the treatment of chronic low back painNathaniel Katz, David G Borenstein, Charles Birbara, et al.
Journal of Opioid Management|February 11, 2012
Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care settingJames Brown, Beatrice Setnik, Keung Lee, et al.
Rheumatology International|December 17, 2014
Development of a bedside pain assessment kit for the classification of patients with osteoarthritisEric Osgood, Jeremiah J Trudeau, Thomas A Eaton, et al.
Pain|January 20, 2015
National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomesArvind Narayana, Nathaniel Katz, Alicia C Shillington, et al.
Journal of Pain Research|August 4, 2017
Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patientsPamela B Landsman-Blumberg, Nathaniel Katz, Kavita Gajria, et al.
Journal of Neurology|September 23, 2018
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trialJohn Markman, Malca Resnick, Scott Greenberg, et al.
Pain Medicine (Malden, Mass.)|June 21, 2008
Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administratorsNathaniel Katz, Brian Houle, Kathrine C Fernandez, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Managed Care Pharmacy : JMCP|July 7, 2005
Direct costs of opioid abuse in an insured population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.
Pain|May 12, 2007
Development and validation of the Current Opioid Misuse MeasureStephen F Butler, Simon H Budman, Kathrine C Fernandez, et al.
Harm Reduction Journal|February 7, 2006
Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusersStephen F Butler, Christine Benoit, Simon H Budman, et al.
Pain|June 24, 2011
Efficacy and safety of tanezumab in the treatment of chronic low back painNathaniel Katz, David G Borenstein, Charles Birbara, et al.
Journal of Opioid Management|February 11, 2012
Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care settingJames Brown, Beatrice Setnik, Keung Lee, et al.
Rheumatology International|December 17, 2014
Development of a bedside pain assessment kit for the classification of patients with osteoarthritisEric Osgood, Jeremiah J Trudeau, Thomas A Eaton, et al.
Pain|January 20, 2015
National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomesArvind Narayana, Nathaniel Katz, Alicia C Shillington, et al.
Journal of Pain Research|August 4, 2017
Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patientsPamela B Landsman-Blumberg, Nathaniel Katz, Kavita Gajria, et al.
Journal of Neurology|September 23, 2018
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trialJohn Markman, Malca Resnick, Scott Greenberg, et al.
Pain Medicine (Malden, Mass.)|June 21, 2008
Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administratorsNathaniel Katz, Brian Houle, Kathrine C Fernandez, et al.
Pageof 7